院前心电图特征作为院外无脉性电活动性心脏骤停预后标志物的效用
该研究前瞻性纳入2007年6月至2009年11月间在渥太华/OPALS站点(复苏结局联盟PRIMED研究)的332例成人非创伤性院外心脏骤停且初始节律为无脉性电活动的患者,分析院前心电图心率、QRS间期及P波对自主循环恢复和出院存活的影响。结果显示存活者与未存活者心率(56.8 vs 52.0次/分,p=0.53)和QRS间期(128.7 vs 129.6 ms,p=0.95)无显著差异,多因素分析中心电图特征均不能预测出院存活或自主循环恢复。出院存活率5.4%,到达急诊时自主循环恢复率26.5%。作者结论认为院前心电图特征不应被用于指导终止复苏决策。
要点
- 在332例无脉性电活动性院外心脏骤停患者中,院前心电图心率、QRS间期和P波均不能预测出院存活或自主循环恢复。
- 存活者与未存活者心率(56.8 vs 52.0次/分,p=0.53)和QRS间期(128.7 vs 129.6 ms,p=0.95)无显著差异。
- 初始心率<30次/分者存活率3.8%,心率<30次/分且QRS≥120 ms者存活率3.7%。
- 心脏骤停地点可预测出院存活(校正OR=1.49,95%CI 1.11–1.99;p=0.007);阿托品使用负向预测出院存活(校正OR=0.06,95%CI 0.02–0.22;p<0.001)。
- 自主循环恢复的正向预测因素为现场高级生命支持急救员(校正OR=8.90,95%CI 1.11–71.41;p=0.04)和插管成功(校正OR=3.35,95%CI 1.75–6.39;p<0.001),阿托品使用为负向预测因素(校正OR=0.27,95%CI 0.14–0.50;p<0.001)。
适用人群与场景
- 成人非创伤性院外心脏骤停患者,初始节律为无脉性电活动且尝试复苏。
- 数据来自2007年6月至2009年11月在渥太华/OPALS站点(复苏结局联盟PRIMED研究)前瞻性纳入的患者。
研究设计与关键结果
- 研究类型为前瞻性队列分析,纳入332例成人非创伤性无脉性电活动性院外心脏骤停患者。
- 出院存活率5.4%,到达急诊时自主循环恢复率26.5%。
- 存活者与未存活者心率(56.8 vs 52.0次/分,p=0.53)和QRS间期(128.7 vs 129.6 ms,p=0.95)无显著差异。
- 多因素分析中院前心电图特征均不能预测出院存活或自主循环恢复。
- 初始心率<30次/分者存活率3.8%;心率<30次/分且QRS≥120 ms者存活率3.7%。
- 心脏骤停地点预测出院存活(校正OR=1.49,95%CI 1.11–1.99;p=0.007);阿托品使用负向预测出院存活(校正OR=0.06,95%CI 0.02–0.22;p<0.001)。
- 自主循环恢复的预测因素:现场高级生命支持急救员(校正OR=8.90,95%CI 1.11–71.41;p=0.04)和插管成功(校正OR=3.35,95%CI 1.75–6.39;p<0.001);阿托品使用负向预测自主循环恢复(校正OR=0.27,95%CI 0.14–0.50;p<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(基于PRIMED研究数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,院前心电图特征不应被用于指导无脉性电活动性院外心脏骤停的终止复苏决策。
- 阿托品使用与出院存活和自主循环恢复的负向预测相关,但原文未给出因果或推荐性结论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: It is unclear if there are predictors of survival, including ECG characteristics, that can guide resuscitative efforts in pulseless electrical activity (PEA) cardiac arrests. We studied the predictive potential of presenting prehospital ECGs on survival for patients with out-of-hospital cardiac arrest (OHCA) with PEA.
METHODS: We studied prehospital ECGs of patients with OHCA prospectively enrolled between June 2007 and November 2009 at the Ottawa/OPALS (Ontario Prehospital Advanced Life Support Study) site of the Resuscitation Outcomes Consortium PRIMED study (Prehospital Resuscitation using an IMpedance valve and Early versus Delayed analysis). We included adult non-traumatic OHCA with PEA rhythm where resuscitation was attempted. We measured HR, QRS interval and presence of P waves, and determined their impact on return of spontaneous circulation (ROSC) and survival to hospital discharge (SHD) using multivariate regression analysis.
RESULTS: The demographic characteristics of the 332 included cases were the following: mean age 71.8, male 58.4%, SHD 5.4% and ROSC at ED arrival 26.5%. Survivors had similar HR (56.8 vs 52.0 beats per minute (bpm), p=0.53) and QRS intervals (128.7 vs 129.6 ms, p=0.95) compared with non-survivors. Prehospital ECG characteristics did not predict SHD or ROSC on multivariate analyses. Patients with initial HR <30 bpm had a 3.8% survival rate; those with both HR <30 bpm and QRS≥120 ms had a 3.7% survival rate. Location of arrest predicted SHD (adjusted OR (AdjOR)=1.49, 1.11 to 1.99; p=0.007). Atropine use negatively predicted SHD (AdjOR=0.06, 0.02 to 0.22; p<0.001). Predictors of ROSC ALS paramedic on scene (AdjOR=8.90, 1.11 to 71.41; p=0.04) and successful intubation (AdjOR=3.35, 1.75 to 6.39; p<0.001). Atropine use negatively predicted ROSC (AdjOR=0.27, 0.14 to 0.50; p<0.001).
CONCLUSIONS: Presenting prehospital ECG characteristics did not predict SHD or ROSC in OHCA PEA victims and should not be used to guide termination of resuscitation. Location of arrest was a positive predictor for SHD; atropine use was a negative predictor. ALS paramedic on scene and successful intubation were positive predictors of ROSC; atropine use was a negative predictor.
TRIAL REGISTRATION NUMBER: NCT00394706; post-results.
参考来源
- Ho ML, Gatien M, Vaillancourt C, et al. Utility of prehospital electrocardiogram characteristics as prognostic markers in out-of-hospital pulseless electrical activity arrests. Emerg Med J. 2017. PMID: 29055890. doi:10.1136/emermed-2017-206878
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。